factual

Cancer Drugs No Longer Need Comparator Arms

Cancer drug studies do not typically have a comparator arm anymore and do not need one to receive FDA approval for a novel therapeutic, which makes the advisory committee's heavy focus on blinding for MDMA surprising by comparison.

factualpending

Speaker

Jennifer Mitchell

Evidence Quote

“you don't need the comparator arm to receive fda approval for a novel therapeutic”

Source

377 - The Future Of Psychedelic Medicine 2— Making Sense with Sam Harris
Created: 6/14/2026, 2:01:41 AM

Your notes

Loading notes...